ANN ARBOR, MICH./JAN. 18, 2018 – The American College of Mohs Surgery has selected ArborMetrix as its technology and analytics partner to power its national MohsAIQ registry.
The ACMS serves as the voice of nearly 1,500 fellowship-trained skin cancer and reconstructive surgeons specializing in the Mohs micrographic surgical technique used to treat skin cancer. The College selected ArborMetrix after an extensive competitive search process.
The MohsAIQ registry, which stands for “Mohs Advancing and Improving Quality,” will support the ACMS mission to promote and advance the highest standards of patient care with respect to Mohs surgery and dermatologic oncology. Ultimately, the registry will help the ACMS and its members demonstrate the value of Mohs surgery as patient-centered, timely, and highly effective.
“We were really looking for a partner to help create a user-friendly and sophisticated data registry to utilize the latest in technical advancements, and to make the delivery and entry of data as easy as possible for our members,” said Howard Rogers, M.D., Vice Chair, ACMS National Registry and Outcomes Committee. “We were also looking for a partner with a track record of success in not just establishing data registries for specialty societies but also one committed to the ultimate success of the registry with a great product and exceptional customer service. ArborMetrix is that partner.”
MohsAIQ will leverage ArborMetrix’s flexible technology infrastructure, advanced analytics, and interactive dashboards to support quality improvement initiatives and clinical research leading to the identification of best practices. Additionally, the ACMS is aiming for members to be able to use MohsAIQ to satisfy quality reporting requirements from the Centers for Medicare and Medicaid Services’ (CMS) Quality Payment Program (QPP), under the Merit-based Incentive Payment System (MIPS) starting in 2019. ArborMetrix will be supporting the ACMS’s self-nomination as a Qualified Clinical Data Registry for 2019.
“The ACMS is dedicated to continuing to advance the art and science of Mohs surgery,” said Spencer Heaton, M.D., M.B.A., Chief Medical Officer, ArborMetrix. “The MohsAIQ registry is going to be the foundation of the future of the specialty. It will prepare the ACMS and Mohs surgeons to succeed through the continued evolutions of care delivery and payment models.”
At ArborMetrix, advancing healthcare through data science is our mission, and delivering high impact, intuitive technology and analytics is our passion. Our leading healthcare intelligence solutions are proven to identify actionable insights that drive physician engagement, advance care, and improve patient outcomes, and our Mercury platform delivers clinically relevant and timely analytics and reports that have been shown to effectively target ways to improve healthcare quality and efficiency. Learn more at ArborMetrix.com.